Brian Piper - 17 Feb 2026 Form 3 Insider Report for Sana Biotechnology, Inc. (SANA)

Signature
/s/ Aaron M. Grossman, Attorney-in-Fact for Brian Piper
Issuer symbol
SANA
Transactions as of
17 Feb 2026
Net transactions value
$0
Form type
3
Filing time
18 Feb 2026, 16:33:51 UTC
Previous filing
27 Aug 2021

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Piper Brian EVP, Chief Financial Officer C/O SANA BIOTECHNOLOGY, INC., 188 EAST BLAINE STREET, SUITE 350, SEATTLE /s/ Aaron M. Grossman, Attorney-in-Fact for Brian Piper 18 Feb 2026 0001665924

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney